4//SEC Filing
Schramm Vern Lee 4
Accession 0001415889-20-000738
CIK 0001604191other
Filed
Mar 12, 8:00 PM ET
Accepted
Mar 13, 4:10 PM ET
Size
7.0 KB
Accession
0001415889-20-000738
Insider Transaction Report
Form 4
Schramm Vern Lee
Director
Transactions
- Award
Common Stock
2020-03-11$1.04/sh+8,414$8,751→ 90,498 total - Award
Common Stock
2020-03-11$0.60/sh+14,584$8,750→ 82,084 total
Footnotes (4)
- [F1]Shares issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending September 30, 2019.
- [F2]Based on the stock price at September 30, 2019, at which time cash compensation would have otherwise been paid for service on the Issuer's Board of Directors.
- [F3]Shares issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending December 31, 2019.
- [F4]Based on the stock price at December 31, 2019, at which time cash compensation would have otherwise been paid for service on the Issuer's Board of Directors.
Documents
Issuer
AzurRx BioPharma, Inc.
CIK 0001604191
Entity typeother
Related Parties
1- filerCIK 0001719553
Filing Metadata
- Form type
- 4
- Filed
- Mar 12, 8:00 PM ET
- Accepted
- Mar 13, 4:10 PM ET
- Size
- 7.0 KB